Saturday, July 4, 2026

#ADC

3 articles

Four Oncology Drugs Face FDA PDUFA Decisions in 2026, Stacking Binary Catalyst Risk Into a Narrow Window

Biotech Sector Catalysts

Four Oncology Drugs Face FDA PDUFA Decisions in 2026, Stacking Binary Catalyst Risk Into a Narrow Window

Salvado•Jun 19, 2026

FDA H2 2026 Oncology Docket Packs Four Major Decisions Into One Catalyst Window

Healthcare Sector

FDA H2 2026 Oncology Docket Packs Four Major Decisions Into One Catalyst Window

Salvado•Jun 17, 2026

Kelun-Biotech Advances 30+ Oncology Candidates as ADC Pipeline Race Accelerates Through 2027

Healthcare Stocks

Kelun-Biotech Advances 30+ Oncology Candidates as ADC Pipeline Race Accelerates Through 2027

Salvado•Mar 26, 2026